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1.  IntroductIon
The use of chemical and biological warfare agents on 
humans, animals and plants to cause harm or death is a concept 
followed by several State Parties and by terrorist organisations1. 
The chemical weapons can cause death and injury through 
its chemical action on the biological system2. The biological 
weapons are bacterial and viral agents that are pathogenic to 
humans and animals, and toxins derived by biological sources3. 
The chemical agents act very fast and its detection and 
protection has to be carried out very quickly. Defence Research 
and Development Organisation has developed a first aid kit that 
contains detection, decontamination and medical protection4. 
The nerve agents like tabun, sarin, soman and VX act rapidly 
and hence for medical protection the antidotes are provided as 
autoinjectors in the first aid kit, for rapid administration and 
faster absorption of drugs.
The autoinjectors are very safe. When given 
intramuscularly the autoinjector can deliver the drugs faster 
with rapid absorption compared to manual injection due to the 
spray effect of drug delivery in autoinjector. In the autoinjector, 
the needle is not visible outside and hence do not cause any 
fear. The injection will be painless, easy to administer and 
well suited for mass casualty management. When healthy 
volunteers were administered atropine and pralidoxime chloride 
through autoinjectors, the drug absorption was faster by the 
autoinjector5. Other than atropine sulphate and pralidoxime 
chloride (nerve agent antidotes), autoinjectors are available 
for few life saving situations viz., epinephrine for anaphylaxis, 
diazepam for status epilepticus, sumatriptan for migraine and 
midazolam for convulsions6.
For bio-threat agents in the first aid kit, doxycycline 
alone is available as a broad spectrum antibiotic for oral 
administration. During training and operation in the military 
service, low intensity conflicts, road accidents and also in 
natural disaster situations, serious injury may occur for 
which an antibiotic may be required. An autoinjector will be 
very useful in such situations. In addition, the antibacterial 
autoinjector can also be used as an antidote for bio-threat 
agents. A concept of development of a probable autoinjector 
for an antibacterial drug and an analgesic drug was earlier 
proposed6,7. Previously, amikacin drug cartridge was 
developed for the existing reusable autoinjector and tested 
in animal models for its tolerance and usability using various 
haematological and biochemical parameters8. All parameters 
viz., liver function test, kidney function test, serum enzymes 
and general biochemical variables did not show any significant 
change9. Since the autoinjector delivers the drug with force, in 
the present study amikacin was delivered intraperitoneally in 
rats by autoinjector and compared with manual injection for 
various oxidative stress parameters. Since, amikacin will be 
effective against most of the gram negative organisms and few 
gram positive organisms, an in vitro study was also carried out 
using combination of antibiotics for its effectiveness for future 
development10.
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2.  MAterIAl And Methods
2.1. Animals  
Female Wistar rats weighing 120 g - 180 g from 
Biomedical Research unit and laboratory Animal Centre, 
Saveetha university were used. The animals were housed in 
polypropylene cages, three per cage with dust free paddy husk 
as the bedding material. They were provided with laboratory 
animal feed (VRK Nutritional, India) and filtered water ad 
libitum. The animals were maintained at a temperature of 25 + 
2 oC and natural dark/light cycle. The study was approved by 
Institutional Animal Ethical Committee of Saveetha university 
(Su/ BRulAC/RD/010/2014).
2.2. drug cartridge and dilution 
Amikacin drug cartridge developed by Saveetha university 
with the collaboration of Defence Research and Development 
Organisation and M/s Neon laboratories (Mumbai), was used 
for the study (as shown in Fig. 1). The drug cartridge was 
developed with human dosage of 250 mg/ml (2.35 ml/vial). 
For the animal administration, the human dose cartridge was 
diluted 1:4, to make the concentration to 63 mg/ml. For this, 
1.75 ml of the drug solution was withdrawn from the cartridge 
in sterile condition using a laminar flow and 1.75 mL of sterile 
saline was injected back. The autoinjector capable of delivering 
full dose with full needle out or partial dose with partial needle 
out was used9. The drug cartridge was loaded in the autoinjector 
with the plastic clip restrictor for partial dose delivery (1.2 ml 
against 2.0 ml) and partial needle out (15 mm against 25 mm), 
since it was an animal study through intraperitoneal route9. 
The refilled amikacin cartridges were subjected to a variety 
of quality control parameters viz., sterility test, firing efficacy 
test, stability test, low pressure test and vibration test.
2.3. experimental Groups 
Thirty five female rats were randomly allocated to the 
following five groups (7 rats per group). 
Group 1 :  Control
Group 2 :  Amikacin, 63 mg/ml (1.2 ml, i.p.) for 3 days by 
autoinjector, 
Group 3 :  Amikacin, 63 mg/ml (1.2 ml, i.p.) for 3 days by 
manual injection. 
Group 4 :  Amikacin, 63 mg/ml (1.2 ml, i.p.) for 7 days by 
autoinjector 
Group 5 :  Amikacin, 63 mg/ml (1.2 ml, i.p.) for 7 days by 
manual injection. 
The rats were held on the surgical table with its back on 
the table gently and firmly. The autoinjector was unlocked 
and positioned gently on the lower abdomen vertically. The 
trigger button was pressed and held on to the abdomen for 
10 seconds. The drug cartridge was weighed before and after 
injection to estimate the quantity of the drug delivered. For 
the manual injection, the drug solution that was removed from 
the cartridge, was diluted suitably with sterile normal saline 
to get a concentration of 63 mg/ml and from that 1.2 ml was 
injected intraperitoneally (i.p.) to each rat. 
2.4. sample collection 
The animals were weighed daily. General behaviour, food 
and water intake were recorded. Twenty four hours after the last 
dose (4th or 8th day), the animals were anaesthetised with isoflurane 
and blood was collected from the orbital sinus in two separate 
tubes, one with anticoagulant (K3EDTA) and the other without 
anticoagulant. After the collection of the blood, the animals were 
sacrificed with a over dose of anaesthesia. Vital organs like heart, 
lungs, spleen, kidney and liver were excised, blotted free of blood, 
weighed and preserved in formalin solution.
2.5. oxidative stress Parameters in Blood
Catalase (CAT), glutathione peroxidase (GPX), superoxide 
dismutase (SOD) and glutathione reductase (GR), were 
estimated using the haemolysate. From the tubes without 
anticoagulant, serum was separated and was used for the 
estimation of malondialdehyde (MDA) and reduced glutathione 
(GSh). Roche’s diagnostic kits (Chennai, India) were used and 
the assays were carried out as per the manufacturer’s instruction 
(expressed as units), in a spectrophotometer (Shimadzu, Japan).
2.6. In vitro test for combination of Antibacterial 
Agents 
Disc diffusion test was performed according to the 
NCClS procedure11. The lawn culture of the test organisms 
were compared to 0.5 Mac Farland standard made on Mueller 
hinton agar (hiMedia, India)12. The antibacterial activity of 
the antibiotics were tested alone and also in combination. 
The plates were incubated at 37 oC for 24 h and the zone of 
inhibition was measured. Two strains were used for the in vitro 
sensitivity test, (i) Pseudomonas aeruginosa as gram negative 
and (ii) Staphylococcus aureus as gram positive. Amikacin 
alone and in combination with cefazolin and vancomycin were 
tested. The tests were done in triplicates. 
Figure 1.  Amikacin drug cartridges for reusable autoinjector, (a) fresh cartridges, (b) partially ejected drug cartridges, and (c) fully 
ejected drug cartridges.
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2.7. statistical Analysis
All the parameters were analysed using one way analysis 
of variance (ANOVA) and compared with control using 
Dunnett’s test. A probability of 0.05 and less was taken as 
statistically significant. The analysis and plotting of graphs 
were carried out using SigmaPlot 12 (SysStat Software Inc., 
uSA).
3.  results
All the animals survived in all the groups. Bleeding or 
abscess was not observed in any of the groups. The food and 
water intake were also apparently similar in all the groups. 
The approximate dose of amikacin administered was 500 mg/
kg and the effective needle length was 15.5 mm. The refilled 
cartridges complied with all the quality control parameters.
There was no significant change in blood GSH and MDA 
levels in 3 d and 7 d groups of autoinjector and manual injection 
when compared to control group as shown in Fig. 2. Similarly, 
no significant change was observed in blood SOD, CAT, GPX 
and GR levels in 3 d and 7 d groups of autoinjector and manual 
injection when compared to control group as shown in Figs. 3 
and 4. 
The results of in vitro test for the antibiotics and their 
combination against gram negative and gram positive organisms 
are given in Table 1. In the case of gram negative organism, 
amikacin alone or its combination with cefazolin or vancomycin 
showed no statistically significant difference, suggesting that 
amikacin alone is adequate. The combination did not show any 
antagonist effect against the gram negative organism. But, in 
the case of gram positive organism, combination with cefazolin 
or vancomycin showed statistically significant effect. 
Figure 2. effect of amikacin administered through autoinjector 
and manual injection by i.p. in rat on reduced 
glutathione (Gsh) and malondialdehyde (MdA), c 
= control Group; A-3 = autoinjector 3 doses; M-3 = 
manual injection 3 doses; A-7=autoinjector 7 doses; 
M-7 = manual injection 7 doses; Mean + se (n = 7) 
one way AnoVA followed by dunnett’s comparison 
test with control group was carried out.
Figure 3. effect of amikacin administered through autoinjector 
and manual injection by i.p. in rat on superoxide 
dismutase (sod) and catalase (cAt), c = control 
Group; A-3 = autoinjector 3 doses; M-3 = manual 
injection 3 doses; A-7 = autoinjector 7 doses; M-7 
= manual injection 7 doses; Mean + se (n = 7), one 
way AnoVA followed by dunnett’s comparison test 
with control group was carried out.
organism Antibiotic Zone of inhibition 
(mm) Mean ± se 
(n=3)
Pseudomonas 
aueroginosa
(Gram negative)
Amikacin 22.14 ± 0.48
Cefazolin 19.55 ± 0.78
Vancomycin 20.76 ± 1.05
Amikacin + Cefazolin 22.25 ± 1.21
Amikacin +Vancomycin 23.35 ± 0.69
 F = 2.80
 P = 0.085
Staphylococcus 
aureus
(Gram positive)
Amikacin 18.25 ± 0.72
Cefazolin 21.67 ± 0.69*
Vancomycin 25.42 ± 0.46*
Amikacin+Cefazolin 22.85 ± 0.90*
Amikacin +Vancomycin 26.25 ± 0.95*
 F = 17.44
 P < 0.001
 *Statistically significant from amikacin
table 1 . In vitro antibacterial activity of antibiotics individually 
and in combination against Pseudomonas aeruginosa 
and Staphylococcus aureus
4. dIscussIon
Several field equipments are available for the rapid 
detection of chemical agents and protection can be taken 
immediately. Additionally, medical protection can be taken 
using the first aid kit4. For the detection of the bio-threat 
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table 2 . characteristics of bacterial bio threat organisms in categories A, B and c, and their drug of choice
organism lethality human exposure Grams reaction drugs -First choice drugs- other alternatives
Category A – Bacterial agents
Bacillus anthrax high Aerosol Gram positive Ciprofloxacin, 
Doxycycline
Clindamycin, Rifampicin, 
Penicillin G
Yersnia pestis high Aerosol Gram negative Streptomycin, 
Doxycycline, 
Amikacin17
Ciprofloxacin, 
Co trimaxazole, Gentamycin, 
Chloramphenicol
Francisella 
tularensis
Moderate Aerosol Gram negative Gentamycin, 
Chloramphenicol, 
Amikacin18
Ciprofloxacin, Doxycycline, 
Levofloxacin
Category B – Bacterial agents
Coxiella burnetti low Aerosol Gram negative Doxycycline Tetracycline
Brucella species Moderate Gram negative Doxycycline+
Streptomycin/
Gentamycin/ 
Amikacin19
Doxycycline+
Rifampicin
Cotrimoxazole+
Rifampicin
Ciprofloxacin+
Rifampicin
Burkholderia 
mallei
low Aerosol Gram negative Cephalosporins
Co trimoxazole
Tetracycline
Aminoglycosides
Amikacin20
Rickettsia 
prowazekii
low Gram negative Doxycycline
Tetracycline
Chloramphenicol
Erythromycin
Salmonella 
Species
high to 
moderate
Food and water Gram negative Fluoroquinolones
Chloramphenicol
Cefoperazone, 
Ceftriaxone
Cotrimoxazole
Amoxicillin
Azithromycin
Shigella 
dysentriae
low Food and water Gram negative Ciprofloxacin Azithromycin, Ceftriaxone, 
Aminoglycosides Amikacin21
Escherichia coli low Food and water Gram negative Fluoroquinolones Amoxycillin+ Clavulanic acid
Amikacin15
Cephalosporin,
Tigecycline, Polymyxin B
Vibrio cholerae high if 
untreated
Food and water Gram negative Doxycycline, 
Tetracycline
Cotrimoxazole,
Chloramphenicol
Fluoroquinolone
Azithromycin, Amikacin22
Category C – Bacterial agents
Mycobacterium 
tuberculosis
MDR strain
high Aerosol Acid fast 
bacterium
Rifampicin
Isoniazid
Streptomycin
Quinolones
Amikacin23
agents, field equipments are available but, their specificity is 
always questionable13. In such a situation, a prophylactic drug 
is essential and amikacin can be administered even in doubt. 
Table 2 lists the bio-threat agents as per Centers for Disease 
Control and Prevention (CDC) classification14. Category A 
includes bacterial agents that possess high risk to the public 
and national security. They can be easily spread or transmitted 
from person to person and result in high death rates and can 
cause public panic. Category B includes agents that are of 
second priority. They are easy to spread and produce moderate 
illness and low lethality. Whereas, category C includes agents 
which are emerging pathogens that could be engineered for 
mass spread in the future. They may cause high morbidity 
and mortality rates and major health impact. Table 3 shows 
the bacterial agents, which are associated with field infections 
viz., military operations, terrorism, accidents and natural 
disasters14. 
The drug of choice for each agent is also given in Tables 
2 and 3. For the majority of the agents, particularly gram 
negative organisms, if a single antibacterial drug is required 
the preference is for amikacin. hence, amikacin drug cartridge 
was developed for the existing autoinjector. This can be 
supplemented with oral doxycycline available in the first aid 
kit. In the present study, amikacin was tested against common 
field bacteria (gram negative and gram positive), in vitro for its 
effectiveness. Amikacin is an amino glycoside antibiotic derived 
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from kanamycin and is highly effective against gram negative 
organisms as well as few gram positive organisms15,16. It is 
also effective against gentamycin resistant strains. Although, 
amikacin is a very effective aminoglycoside against most of 
the gram negative organisms, it cannot be recommended for all 
the gram positive organisms. So a combination of antibiotics 
that can act against various gram negative and gram positive 
organisms will be useful in field administration. Combined 
antibiotic therapy is also useful in preventing resistance 
development and to enhance antibiotic efficacy15.
Unlike the chemical agents, for a specific detection the 
bio-threat agents require more time. Till the specific detection, 
prophylactic drug treatment is required. For gram negative 
organisms and also as a supportive treatment for gram positive 
organisms, amikacin is preferable. For viral agents and also 
for toxins, amikacin can be administered as a supportive 
therapy. The advantage of amikacin is its safety, stability and 
can be supplemented with other antibiotics when medical 
attention arrives. With the use of dual dose autoinjector, 
amikacin can be given to children and also for pet and farm 
animals. For biodefence, an antibiotic in an autoinjector is 
very essential. Amikacin is effective against most of the gram 
negative organisms. The present in vitro study revealed that 
a combination with either cefozolin or vancomycin can be 
considered for future development as autoinjector cartridge for 
the existing autoinjectors. 
The usability and tolerability of amikacin administered 
repeatedly through autoinjectors was earlier studied using 
Table 3 . Characteristics of bacterial agents associated with field infections and their drug of choice
Figure 4. effect of amikacin administered through autoinjector 
and manual injection by i.p. in rat on glutathione 
peroxidase (GPX) and glutathione reductase (Gr), c 
= control Group; A-3 = autoinjector 3 doses; M-3 = 
manual injection 3 doses; A-7 = autoinjector 7 doses; 
M-7 = manual injection 7 doses; Mean + se (n = 7), 
one way AnoVA followed by dunnett’s comparison 
test with control group was carried out.
organism lethality Grams reaction Drugs -first choice drugs- other alternatives
Staphylococcus 
aureus
low  Gram positive Penicillin G
Methicillin
Vancomycin
linezolid
Nafcillin
Oxacillin
Daptomycin
Amikacin24
Streptococcus 
pyogenes
low Gram positive Penicillin G or V Cephalosporin
Erythromycin
Azithromycin
Clindamycin
Enterococcus 
faecalis
low Gram positive Penicillin G/
Vamcomycin+ gentamycin
Ampicillin + Sulbactum + 
Imepenem
Clostridium 
perfringens
high Gram positive 
[Anaerobe]
Metronidazole
Gentamycin and amoxicillin
Clindamycin
Clostridium 
tetani
high Gram positive 
[Anaerobe]
Penicillin G, Metronidazole Clindamycin
Pseudomonas 
aeruginosa
low Gram negative Ceftazidime
Cefepime
Amikacin24
Aztreonam
Meropenem
E. coli low Gram negative Fluoroquinolones Amoxycillin+ clavulanic acid
Amikacin15
Cephalosporin,
Tigecycline, Polymyxin B
Klebsiella 
species
low Gram negative Imipenem, 
Amikacin15
Third generation 
cephalosporin, Cotrimaxazole
Proteus species low Gram negative Amikacin15
Cotrimoxazole
Imipenem
First generation cephalosporin
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various haematological and biochemical parameters in 
animal models8,9. The autoinjectors are self injectable medical 
devices and are intended for intramuscular or subcutaneous 
administration. To prove its safety, in the present study the 
amikacin autoinjector was administered intraperitoneally in rat, 
where the drug would be delivered with force on the abdominal 
vital organs. hence, oxidative stress parameters were carried 
out in blood. The repeated administration of amikacin both by 
autoinjector and manual injection did not cause any change in 
the oxidative stress parameters. Though, autoinjector delivers 
the drug with a spray effect and with high force, no abnormality 
was detected in the rats when administered intraperitoneally, 
showing that autoinjectors are safe.
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